A fork with timer for providing a cue to a user after an elapsed period of time for indicating that another bite of food using the fork may be taken.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7335373 | Biocidal siloxane coating material containing N-halogenated amine and amide functional groups N-halamine compounds which contain hindered amine and amide functional groups. Compounds include wherein X, X′, and X″ independently are H, Cl, or Br, wherein no more than two of X, X′, and X″ are H and | 02/26/2008 |
| 7311970 | Medical device having surface modification with superoxide dismutase mimic A medical device comprising a substrate having a plasma polymerized functionality bonded to at least a portion of the substrate. A superoxide dismutase mimic agent having a complimentary functional group to the plasma polymerized functionality is bonded to the porti... | 12/25/2007 |
| 7309696 | Compositions and methods for targeting cancer cells The invention includes compositions and methods useful for treatment of a virus infection in a mammal by double-targeting the virus (i.e. targeting the virus at more than one stage of the virus life cycle) and thereby inhibiting virus replication. The compositions o... | 12/18/2007 |
| 7294621 | Lipid analogs for combating tumors The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative to inhibit the ... | 11/13/2007 |
| 7294620 | Lipid analogs for inhibiting HIV-1 activity The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative to inhibit the ... | 11/13/2007 |
| 7294619 | Lipid analogs for inhibiting the activity of hepatitis B antigen The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative to inhibit the ... | 11/13/2007 |
| 7285157 | Air filter An air-filter for a circulating and/or recirculating air system using a filter medium containing a microbiologically effective amount of a polymeric biguanide or salt thereof. Also claimed is a method for reducing odors and/or air-borne micro-organisms in a circulat... | 10/23/2007 |
| 7229613 | Method for lowering serum glucose A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polym... | 06/12/2007 |
| 7195615 | System for providing a medical device with anti-microbial properties A system for providing medical device with anti-microbial properties to prevent infections. The system includes a medical device having a portion for insertion into the body of a patient, a lumen, and a substrate comprising an anti-microbial agent to be inserted int... | 03/27/2007 |
| 7175895 | Glove with medicated porous beads An elastomeric article includes a substrate body formed from an elastomeric material, and a plurality of porous beads capable of containing a treatment within the pores of the beads and dispensing the treatment to an end user. ... | 02/13/2007 |
| 7141557 | Lipid analogs for treating viral infections A method of treating viral infections, and in particular HIV-1, hepatitis B virus, and herpes virus, is disclosed. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative.... | 11/28/2006 |
| 7064168 | AB block copolymers containing poly (vinyl pyrrolidone) units, medical devices, and methods AnB block copolymers, wherein n is at least two, that include A blocks with poly(vinyl pyrrolidone) units and B blocks with urethane groups, urea groups, imide groups, amide groups, ether groups, ester groups, or combinations thereof, as well as medical d... | 06/20/2006 |
| 7048917 | Fat-binding polymers The present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament. Th... | 05/23/2006 |
| 7041281 | Natural feel polymers Natural feel polymers exhibit an advantageous blend of flexibility and a strong affinity to natural fibers imparting a natural feel when applied to keratin-based fibers, e.g. hair, skin, or textiles, e.g. cotton, wool, and are water-soluble and water-resistant. The ... | 05/09/2006 |
| 7026469 | Compositions and methods of double-targeting virus infections and cancer cells The invention includes compositions and methods useful for treatment of a virus infection in a mammal by double-targeting the virus (i.e. targeting the virus at more than one stage of the virus life cycle) and thereby inhibiting virus replication. The compositions o... | 04/11/2006 |
| 7018625 | Personal care compositions Personal care compositions, particularly hair care products, include a polymer mixture made from (A) a derivatized polymer of maleic anhydride having defined repeat units of a monomer (e.g. α-olefin) maleic anhydride alkyl half-ester or full acid, maleamic acid and... | 03/28/2006 |
| 7014781 | Methods and articles for maintaining hydantoinylated polymers in a biocidally active state A composition and the method for sustaining the biocidal activity of chlorinated polystyrene hydantoin beads. The method comprises supplying a continuous low level halogen concentration to the chlorinated polystyrene hydantoin beads in the water to be treated that f... | 03/21/2006 |
| 7005125 | Personal care products Personal care products, particularly hair care products, are made herein by mixing (A) a polymer having defined repeat units of a monomer (e.g. α-olefin) maleic anhydride alkyl half-ester or full acid, maleamic acid and maleimide, which is derivatized with an amine... | 02/28/2006 |
| 6955806 | Ionene polymers and their use as antimicrobial agents Disclosed are ionene polymers having antimicrobial activity. “Ionene polymers” as used in this invention are cationic polymers in which a substantial proportion of the atoms providing the positive charge are quaternized nitrogens located in the main polymeric ch... | 10/18/2005 |
| 6939569 | Medical device having anti-infective and contraceptive properties There is disclosed a medical device for implantation that acts to prevent transmission of infectious agents. Specifically, the present invention provides implantable devices, such as catheters or living skin matrices or wound dressings, for insertion into various bo... | 09/06/2005 |
| 6916480 | Wiper containing a controlled-release anti-microbial agent A wiper having a controlled release anti-microbial agent therein for providing anti-microbial cleansing of surfaces is provided. The wiper is formed from an absorbent base web to which an anti-microbial formulation is adhered. The formulation includes an anti-microb... | 07/12/2005 |
| 6852312 | Biocidal polystyrene hydantoin particles Method for preparing biocidal halogenated polystyrene hydantoins. The biocidal polymers poly-1,3-dichloro-5-methyl-5-(4′-vinylphenyl)hydantoin, poly-1,3-dibromo-5-methyl-5-(4′-vinylphenyl)hydantoin, and their monohalogenated alkali metal salts and protonated der... | 02/08/2005 |
| 6828308 | Compositions and methods for the treatment or prevention of inflammation The present invention relates to compounds containing as active ingredients hyaluronic acid and polyvinylpyrrolidone, for the treatment of inflammatory, ulcerative and painful conditions of moist epithelial surfaces such as mucositis, stomatitis, vestibulitis, aphth... | 12/07/2004 |
| 6756449 | AnB block copolymers containing poly (vinyl pyrrolidone) units, medical devices, and methods AnB block copolymers, wherein n is at least two, that include A blocks with poly(vinyl pyrrolidone) units and B blocks with urethane groups, urea groups, imide groups, amide groups, ether groups, ester groups, or combinations thereof, as well as medical d... | 06/29/2004 |
| 6733980 | Diagnostic method for detection of molecular forms of eosinophilic cationic protein (ISO-ECPS) Diagnostic methods comprise measuring specifically the level of at least one iso-eosinophilic cationic protein (iso-ECP) in a sample from an individual to be diagnosed, and comparing the measured level of the iso-ECP with a predetermined level of the iso-ECP. The is... | 05/11/2004 |
| 6660255 | Inhibition of gene transcription by polyamide DNA-binding ligands The invention provides polyamides suitable for modulating cellular or viral gene expression by binding to an identified target DNA sequence adjacent to the binding site of a minor groove transcription factor protein. The polyamides of the present inventio... | 12/09/2003 |
| 6645483 | Lubricious coating A lubricant coating vehicle for medical devices used to reduce the coefficient of friction of such devices upon exposure thereof to moisture. The lubricant coating vehicle allows the introduction of a pharmacological additive having a release rate that is... | 11/11/2003 |
| 6623729 | Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer The present invention relates to a process of preparing a sustained release micelle by copolymerizing a biodegradable polyester hydrophobic polymer and a hydrophilic polyethylene glycol (PEG) to obtain a block copolymer, reacting the block copolymer with ... | 09/23/2003 |
| 6610282 | Polymeric controlled release compositions Disclosed are compositions containing biologically active compounds that slowly release the biologically active compound. These compositions may be directly incorporated into the locus to be protected or may be applied to a structure in a coating.... | 08/26/2003 |
| 6548054 | Biocidal polystyrene hydantoin particles Method for preparing biocidal halogenated polystyrene hydantoins. The biocidal polymers poly-1,3-dichloro-5-methyl-5-(4'-vinylphenyl)hydantoin, poly-1,3-dibromo-5-methyl-5-(4'-vinylphenyl)hydantoin, and their monohalogenated alkali metal salts and protona... | 04/15/2003 |
| 6511949 | Ophthalmic composition with regulated viscosity An ophthalmic composition having regulated viscosity characterized in that it contains polyoxyethylene polyoxypropylene glycol or polyoxyethylene-polyoxypropylene-substituted ethylenediamine in association with a pharmaceutically acceptable thickener and ... | 01/28/2003 |
| 6482392 | Aerosol antimicrobial compositions An aerosol antimicrobial composition is provided with the following ingredients: a) an anionic polymer or prepolymer; (b) a quaternary ammonium compound, the components (a) and (b) combining to form an antimicrobially effective complex; (c) at least one w... | 11/19/2002 |
| 6479725 | Method of treatment of a wound or incision A method for forming an incision or wound dressing. First, second, and third layers 2-octyl cyanoacrylate adhesive 18, 20, and 22 are applied to a wound or incision site 14, with each layer covering the site 14 and extending to at least about five millime... | 11/12/2002 |
| 6419916 | Assay for compounds which affect conformationally altered proteins An assay comprises contacting cells containing a conformationally altered protein with test compound and determining if the altered protein is cleared. The cells may be scrapie-infected neuroblastoma cells. Another assay comprises contacting organ or tiss... | 07/16/2002 |
| 6337130 | Acid-triggered release microcapsules Microcapsules of a microcapsule formed of a polyurea shell wall and an encapsulated ingredient or ingredients enclosed within the wall, the wall comprising at least one oligomeric acetal having the moiety ##STR1## in which R is (a) a moiety containing a c... | 01/08/2002 |
| 6271264 | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants The present invention relates to a method for sequestering bile acids in a patient and to particular polymers for use in the method. The method comprises administering a therapeutically effective amount of a spirobicyclic ammonium moiety-containing polyme... | 08/07/2001 |
| 6214366 | Clearance and inhibition of conformationally altered proteins The present invention provides a method of arresting, preventing and/or reversing the impairment of central and peripheral nervous system function comprising reducing insoluble protein deposit burden by the administration of branched polycationic compound... | 04/10/2001 |
| 6203856 | Process for the preparation of antimicrobial plastics Antimicrobial activity is imparted to the surface(s) of an apparatus or article by a method, comprising: copolymerizing tertbutylaminoethyl methacrylate with at least one other aliphatically unsaturated monomer in the presence of said apparatus or article... | 03/20/2001 |
| 6190688 | Material for elimination or detoxification of super antigens A material with excellent selective absorption of super antigens. Said material contains urea bonds or thiourea bonds and remains active even in a high protein concentration solution in the neutral region, Activity remains after sterilization. Also provid... | 02/20/2001 |
| 6180127 | Slow release insect repellents This invention discloses slow release formulations for use in application of volatile insect repellents. A copolymer of polyvinyl pyrrolidone and an alkyl group of 4-30 carbons provides the slow release properties. The formulations are characterized by hi... | 01/30/2001 |